Bone Biologics Corp expected to post a loss of 58 cents a share - Earnings Preview

Bone Biologics

05/08/2025 21:32

Bone Biologics Corp BBLG.OQ BBLG.O is expected to  show no change in quarterly revenue when it reports  results on August 7 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Bone Biologics Corp is for a loss of 58 cents per share.

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Bone Biologics Corp is $22.50, about 87.8% above its last closing price of $2.74

This summary was machine generated August 5 at 20:32 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)